ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,888Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 487

$556K Total Retail Price of All Prescriptions

Rank: 28 out of 487

469 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 397 244 S3 1 3
OMEPRAZOLE 326 239 2 2
FUROSEMIDE 300 250 3 7
AMLODIPINE BESYLATE 261 194 4 6
LEVOTHYROXINE SODIUM 222 154 5 1
LISINOPRIL 192 140 6 5
RANITIDINE HCL 167 82 7 39
SIMVASTATIN 146 117 8 4
ATORVASTATIN CALCIUM 127 114 9 18
METFORMIN HCL 123 95 10 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 90 11 24
METOPROLOL SUCCINATE 109 102 12 15
ZOLPIDEM TARTRATE 105 55 13 14
CRESTOR 102 63 14 42
SPIRIVA 96 82 15 48
GABAPENTIN 93 84 16 13
METOPROLOL TARTRATE 90 74 17 17
TAMSULOSIN HCL 78 77 18 25
OXYCODONE HCL 76 34 S2 19 57
NEXIUM 76 53 19 41
CALCITRIOL 71 58 21 218
TRAZODONE HCL 68 25 22 22
CARVEDILOL 66 46 23 32
CARISOPRODOL 66 0 R 23 76
CITALOPRAM HBR 65 45 25 12
SPIRONOLACTONE 65 59 25 43
METHADONE HCL 62 21 S2 27 65
ALENDRONATE SODIUM 61 55 28 27
MORPHINE SULFATE ER 59 17 S2 29 54
ESCITALOPRAM OXALATE 58 34 30 75
FENOFIBRATE 57 41 31 61
FLUOXETINE HCL 56 21 32 28
LOSARTAN POTASSIUM 55 54 33 16
SERTRALINE HCL 54 51 34 21
PRAVASTATIN SODIUM 53 45 35 20
ADVAIR DISKUS 53 50 35 46
MELOXICAM 52 32 37 26
VENLAFAXINE HCL ER 50 15 38 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.